Sujay Kango

Directeur Général chez Tmunity Therapeutics, Inc.

Fortune : - $ au 31/01/2024

60 ans

100 relations

Health Technology

Consumer Services

Health Services

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Justin File	M	53	MEI PHARMA, INC.	1 ans
Tom Glocer	M	63	MERCK & CO., INC.	17 ans
Rebecca Roberts	F	71	ABBVIE INC.	6 ans
Carl June	M	70	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Melody Meyer	F	66	ABBVIE INC.	7 ans
Dalton Smart	M	58	MERCK & CO., INC.	15 ans
Chirfi Guindo	M	58	MERCK & CO., INC.	13 ans
Denise Williams	F	-	MERCK & CO., INC.	15 ans
James Flynn	M	43	MEI PHARMA, INC.	1 ans
Caroline Ruiz	F	-	MEI PHARMA, INC.	2 ans
Jason Sausser	M	-	MEI PHARMA, INC.	2 ans
Steven Graziano	M	-	MERCK & CO., INC.	18 ans
Taheer Mehboob Datoo	M	33	MEI PHARMA, INC.	1 ans
Steven Wood	M	41	MEI PHARMA, INC.	1 ans
Judith Li	F	40	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Pamela Eisele	F	-	MERCK & CO., INC.	15 ans
Beth Seidenberg	M	67	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Sanat Chattopadhyay	M	-	MERCK & CO., INC.	15 ans
Anne Frese	F	-	MEI PHARMA, INC.	2 ans
Garry Nicholson	M	69	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 ans
Patrick M. Gray	M	75	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 ans
Jorge Conde	M	47	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 ans
Sean Parker	M	44	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	6 ans
Li Ming	M	-	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-

Graphique Relationnel

Relation dans plusieurs entreprises

Anciennes relations

Nom	Sexe	Age	Sociétés liées	Collaboration
Lawrence Bloch	M	58	INFINITY PHARMACEUTICALS, INC.	11 ans
N. Coles	M	63	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	5 ans
Daniel Gold	M	70	MEI PHARMA, INC.	13 ans
Fred Hassan	M	78	MERCK & CO., INC.	6 ans
Brian Drazba	M	63	MEI PHARMA, INC.	6 ans
Christine Anna White	M	72	MEI PHARMA, INC.	13 ans
David J. Scott	M	71	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	-
Ofir Moreno	M	-	MEI PHARMA, INC.	12 ans
Robert Iannone	M	57	MERCK & CO., INC.	6 ans
Ismail Kola	M	67	MERCK & CO., INC.	4 ans
Jaren Madden	F	-	INFINITY PHARMACEUTICALS, INC.	7 ans
Tamar Howson	F	75	MEI PHARMA, INC.	4 ans
Carole A. Sable	M	62	MERCK & CO., INC.	16 ans
William Ringo	M	78	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 ans
Thomas Robert Cech	M	76	MERCK & CO., INC.	-
Thomas Wiggans	M	72	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	8 ans
Kenneth Bartizal	M	72	MERCK & CO., INC.	20 ans
Wendy Yarno	F	69	MERCK & CO., INC.	9 ans
Craig Thompson	M	71	MERCK & CO., INC.	10 ans
Harry R. Jacobson	M	76	MERCK & CO., INC.	3 ans
Vito Palombella	M	61	INFINITY PHARMACEUTICALS, INC.	12 ans
Julie Gerberding	M	69	MERCK & CO., INC.	-
Gwen A. Fyfe	M	72	INFINITY PHARMACEUTICALS, INC.	4 ans
Wendell Wierenga	M	76	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	17 ans
Magnus Åke Lundberg	M	68	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	13 ans
Paul Goddard	M	74	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	16 ans
Cheryl L. Cohen	F	58	MEI PHARMA, INC.	2 ans
Pablo Cagnoni	M	60	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 ans
Carlos Eduardo Represas de Almeida	M	78	MERCK & CO., INC.	-
Leslie Brun	M	72	MERCK & CO., INC.	13 ans
Caroline Dorsa	F	64	MERCK & CO., INC.	22 ans
Richard Henriques	M	68	MERCK & CO., INC.	27 ans
Natarajan Sethuraman	M	62	MERCK & CO., INC.	10 ans
Antonio J. Grillo-López	M	84	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	11 ans
Christopher M. Lindblom	M	52	INFINITY PHARMACEUTICALS, INC.	-
Helen Torley	M	61	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 ans
Kevan E. Clemens	M	80	MEI PHARMA, INC.	7 ans
Jean-Marie Canan	M	68	MERCK & CO., INC.	5 ans
Eric S. Lander	M	67	INFINITY PHARMACEUTICALS, INC.	10 ans
William N. Kelley	M	84	MERCK & CO., INC.	-
Sriram Ryali	M	43	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 ans
Steven Goldstone	M	78	MERCK & CO., INC.	6 ans
Samuel Agresta	M	51	INFINITY PHARMACEUTICALS, INC.	5 ans
David Anstice	M	75	MERCK & CO., INC.	5 ans
Christine Cioffe	F	-	MERCK & CO., INC.	20 ans
Anastasia Daifotis	M	-	MERCK & CO., INC.	-
Wei Tang	M	-	MERCK & CO., INC.	15 ans
Andrew Plump	M	58	MERCK & CO., INC.	-
Jens Renstrup	M	59	MERCK & CO., INC.	8 ans
James F. Fuqua	M	-	MERCK & CO., INC.	31 ans
Louisa Shaw-Marotto	F	56	MERCK & CO., INC.	3 ans
Lu Amy Sun	M	67	MERCK & CO., INC.	7 ans
Karen Ling	F	60	MERCK & CO., INC.	6 ans
Maude Tessier	M	46	MERCK & CO., INC.	6 ans
Barry Goldstein	M	-	MERCK & CO., INC.	5 ans
Mark C. Twyman	M	63	MERCK & CO., INC.	18 ans
Steven Hubrig Koehler	M	73	MERCK & CO., INC.	2 ans
Kathleen Metters	M	66	MERCK & CO., INC.	13 ans
Samuel O. Thier	M	86	MERCK & CO., INC.	16 ans
Bradley Sheares	M	67	MERCK & CO., INC.	19 ans
Richard Murray	M	65	MERCK & CO., INC.	5 ans
Martin Duvall	M	62	MERCK & CO., INC.	1 ans
Christina Morrison	F	57	MERCK & CO., INC.	4 ans
David Mauro	M	59	MERCK & CO., INC.	7 ans
Larry Bossidy	M	89	MERCK & CO., INC.	14 ans
Judy Lewent	F	75	MERCK & CO., INC.	27 ans
Margaret McGlynn	F	64	MERCK & CO., INC.	11 ans
Eric Schadt	M	59	MERCK & CO., INC.	8 ans
Per Wold-Olsen	M	76	MERCK & CO., INC.	32 ans
C. Nicholson	M	68	MERCK & CO., INC.	2 ans
Janelle Anderson	M	51	MERCK & CO., INC.	6 ans
François Martelet	M	64	MERCK & CO., INC.	2 ans
Deborah Law	M	-	MERCK & CO., INC.	4 ans
Bruce A. Beutel	M	60	MERCK & CO., INC.	-
Aaron Dent	M	-	MERCK & CO., INC.	6 ans
Jim Robinson	M	-	MERCK & CO., INC.	5 ans

Statistiques

Pays	Relations	% du total
Etats-Unis	100	100,00%

Age des relations

Actives

Passées

Homme

Femme

Administrateurs

Exécutifs

Provenance des relations

Bourse
Insiders
Sujay Kango
Réseau Personnel